Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20121
20152
20161
20172
20182
20193
20206
20213
20225
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
AnchorDx Medical Co., Ltd.1
AstraZeneca1
Bristol-Myers Squibb1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Chengdu CoenBiotech Co., Ltd1
Dragonboat Biopharmaceutical Company Limited1
First Affiliated Hospital Xi'an Jiaotong University1
Fuda Cancer Hospital, Guangzhou1
Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms31
Carcinoma, Transitional Cell4
Stomach Neoplasms3
Breast Neoplasms2
Carcinoma, Renal Cell2
Ovarian Neoplasms2
Prostatic Neoplasms2
Thyroid Neoplasms2
Adrenal Gland Neoplasms1
Biliary Tract Neoplasms1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.